Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Clinical trial NCT03332576 · COMPLETED
Trial details
- NCT number
- NCT03332576
- Sponsor
- ImmunoVaccine Technologies, Inc. (IMV Inc.)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-23
- Primary completion
- 2016-09-08
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.